Answers are grounded in this paper and cite their sources.
Background: Treponemal serological assays are assumed to remain reactive for life following syphilis infection. We established the frequency and characteristics of treponemal seroreversion in people with HIV (PWH) and syphilis, in contrast with false-positive serological treponemal results. Methods: Retrospective cohort of PWH with syphilis diagnosis from January 2001 to June 2025. Treponemal seroreversion was defined as prior syphilis diagnosis with negative non-treponemal (RPR, rapid plasma reagin) and negativization of one treponemal assay (CMIA, chemiluminescent immunoassay; or TPHA, T.pallidum hemagglutination) during follow up. False-positive reactivity was defined as reactive treponemal results and negative both non-treponemal and TPHA results. Results: During follow up, we identified 27 cases (6%) of discordant serological results in 467 episodes. Seroreversion was confirmed in 23 cases (5%), with three different presentations: 5 PWH (1%) with primary syphilis rapidly treated who achieved a rapid TPHA negativization; 10 cases (2%) treated during primary syphilis with progressive waning of antibodies and finally seroreversion of TPHA; and 8 (2%) previous cases of syphilis at different stages with decreasing antibodies during follow up. Of note, the cases of seroreversion after primary stage represented 26% of primary syphilis stage diagnosed. Finally, there were 4 PWH (<1%) with probable false-positive treponemal results, in all the cases with a very low level of antibodies by CMIA. Conclusions: Treponemal seroreversion is the most frequent cause of discordant syphilis serological results in our cohort, and it is frequent as result of early treatment or/and longer follow up. In this population, a false-positive treponemal result is exceptional.
No takes yet. Share an insight, caveat, or question.
Casado et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: